Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus

Cytokine

Volumn 80, Issue , 2016, Pages 48-55

  Zhao, Lan Juan ^a   He, Sheng Fei ^a   Wang, Wen ^a   Ren, Hao ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis C virus; Interferon alpha; Signal transducer and activator of transcription 3; Suppressor of cytokine signaling 3

Indexed keywords

ALPHA INTERFERON; JANUS KINASE 1; PROTEIN KINASE TYK2; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; ALPHA2A INTERFERON; RECOMBINANT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; GENE EXPRESSION REGULATION; GENETICS; HEPACIVIRUS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VIRUS REPLICATION;

EID: 84959347832     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.08.264     Document Type: Article

References (32)

1. Larrea E., Aldabe R., Molano E., Fernandez-Rodriguez C.M., Ametzazurra A., Civeira M.P., et al. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut 2006, 55:1188-1196.
2. Ihle J.N. The Stat family in cytokine signaling. Curr. Opin. Cell Biol. 2001, 13:211-217.
3. Yang C.H., Murti A., Pfeffer L.M. STAT3 complements defects in an interferon resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc. Natl. Acad. Sci. USA 1998, 95:5568-5572.
4. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
5. Vermehren J., Sarrazin C. New hepatitis C therapies in clinical development. Eur. J. Med. Res. 2011, 6:303-314.
6. Li Y., Zhang Q., Liu Y., Luo Z., Kang L., Qu J., et al. Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways. J. Virol. 2012, 86:12531-12543.
7. Stevenson N.J., Bourke N.M., Ryan E.J., Binder M., Fanning L., Johnston J.A., et al. Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett. 2013, 587:1571-1578.
8. Miyaaki H., Ichikawa T., Nakao K., Takeshita S., Shibata H., Ozawa E., et al. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C. Intervirology 2008, 51:394-399.
9. McCartney E.M., Helbig K.J., Narayana S.K., Eyre N.S., Aloia A.L., Beard M.R. Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology 2013, 58:1558-1568.
10. Zhu H., Shang X., Terada N., Liu C. STAT3 induces anti-hepatitis C viral activity in liver cells. Biochem. Biophys. Res. Commun. 2004, 24:518-528.
11. Ryan J.D., Altamura S., Devitt E., Mullins S., Lawless M.W., Muckenthaler M.U., et al. Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. Hepatology 2012, 56:492-500.
12. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem. Cells 2001, 19:378-387.
13. Song M.M., Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 1998, 273:35056-35062.
14. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., et al. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 2004, 78:6282-6286.
15. Bode J.G., Ludwig S., Ehrhardt C., Albrecht U., Erhardt A., Schaper F., et al. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 2003, 17:488-490.
16. Persico M., Capasso M., Russo R., Persico E., Crocè L., Tiribelli C., et al. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 2008, 57:507-515.
17. Zhao L.J., Wang W., Liu Y., Ren H., Qi Z.T. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin. Antiviral Res. 2012, 96:260-268.
18. Zhu H., Zhao H., Collins C.D., Eckenrode S.E., Run Q., McIndoe R.A., et al. Gene expression associated with interferon alpha antiviral activity in an HCV replicon cell line. Hepatology 2003, 37:1180-1188.
19. Pazienza V., Vinciguerra M., Andriulli A., Mangia A. Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-(gamma) in Huh-7 cells. J. Gen. Virol. 2010, 91:1678-1686.
20. van Boxel-Dezaire A.H., Rani M.R., Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25:361-372.
21. Blindenbacher A., Duong F.H., Hunziker L., Stutvoet S.T., Wang X., Terracciano L., et al. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 2003, 124:1465-1475.
22. Lin R.J., Liao C.L., Lin E., Lin Y.L. Blocking of the alpha interferon-induced JAK-STAT signaling pathway by Japanese encephalitis virus infection. J. Virol. 2004, 78:9285-9294.
23. Pugnale P., Pazienza V., Guilloux K., Negro F. Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2009, 49:398-406.
24. Dong C., Zafrullah M., Mixson-Hayden T., Dai X., Liang J., Meng J., et al. Suppression of interferon-α signaling by hepatitis E virus. Hepatology 2012, 55:1324-1332.
25. Wang W.B., Levy D.E., Lee C.K. STAT3 negatively regulates type I IFN-mediated antiviral response. J. Immunol. 2011, 187:2578-2585.
26. Li Y., de Haar C., Peppelenbosch M.P., van der Woude C.J. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine Growth Factor Rev. 2012, 23:127-138.
27. Walsh M.J., Jonsson J.R., Richardson M.M., Lipka G.M., Purdie D.M., Clouston A.D., et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 2006, 55:529-535.
28. Persico M., Capasso M., Persico E., Svelto M., Russo R., Spano D., et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Hepatology 2007, 46:1009-1015.
29. Shao R.X., Zhang L., Hong Z., Goto K., Cheng D., Chen W.C., et al. SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication. Antiviral Res. 2013, 97:101-107.
30. Icardi L., Lievens S., Mori R., Piessevaux J., De Cauwer L., De Bosscher K., et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J. 2012, 26:240-249.
31. Zhu H., Nelson D.R., Crawford J.M., Liu C. Defective JAK-STAT activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J. Interferon Cytokine Res. 2005, 25:528-539.
32. Huang Y., Feld J.J., Sapp R.K., Nanda S., Lin J.H., Blatt L.M., et al. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology 2007, 132:733-744.